Form D · Biotechnology
Pyramid Biosciences, Inc.
Waltham, MA · CIK 0001746835
Offering snapshot reported Oct 15, 2021 · SEC filing
- Reported sold
- $33.5M Indefinite offering
- Investors reported
- 56 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 1, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2021 | Initial | $33,538,989 | No comparison | 56 | SEC filing |
| Aug 14, 2020 | Initial | $8,797,942 | No comparison | 48 | SEC filing |
| Jul 30, 2020 | Initial | $3,632,478 | No comparison | 50 | SEC filing |
| Jul 30, 2020 | Initial | $6,000,000 | No comparison | 103 | SEC filing |
| Aug 2, 2018 | Initial | $17,336 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-417243
Source: Form D, filed Oct 15, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Childs | Director |
| Vladimir Coric | Director |
| Larry Feinberg | Director |
| Jordan Leef | Director, Executive |
| Kollol Pal | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
330 Bear Hill Road Suite 302
Waltham, MA, 02451
Waltham, MA, 02451